All News

The FDA has approved pembrolizumab in combination with lenvatinib for the treatment of advanced endometrial carcinoma that is not microsatellite instability-high or mismatch repair deficient

Although she said it is unlikely that the FDA will retract the approval, prescribers could be reluctant to administer aducanumab to patients.

The results indicated that T cell responses—including CD8+ T cells, which seek out and destroy infected cells—persisted over the 8-month timeframe of the study, according to the authors.

During a presentation at the 2021 annual meeting of the American Association of Colleges of Pharmacy, the presenters broke down how best to engage colleges of pharmacy to help in establishing payer-provider relationships.

How should pharmacists manage a patient with diabetes on metformin with GFR below 30?

Because white meat, unprocessed red meat, dairy, starch, fruit, vegetables, and legumes were not associated with the development of IBD, the way that the food is processed may confer this risk of IBD, rather than the food itself.

Pharmacy Times interviewed Dennis O’Neill, president and board member of BIOMEDICAN, on the outlook around the future of biosynthesis therapeutics that use rare cannabinoids to treat a range of health issues, from mental health disorders to diabetes.

Venetoclax is already approved for the treatment of adults with chronic lymphocytic leukemia or small lymphocytic lymphoma, and in some adults with newly diagnosed acute myeloid leukemia.

Patients treated with berubicin in clinical trials appeared to demonstrate positive responses, including 1 durable complete response in a phase 1 human clinical trial.

Pharmacy clinical services managers administer vaccines, provide education, and serve as leaders in the profession.

Pharmacy Times interviewed Craig Freyer, PharmD, BCOP, and Andrew Lin, PharmD, BCOP, to discuss the emerging data around BCMA-targeted CAR T-cell therapy in multiple myeloma.

Ken Perez, MBA, vice president of healthcare policy and government affairs at Omnicell, outlined what has led to legislation granting pharmacists provider status gaining bipartisan support.

Being clear on your goals as a mentee while creating a partnership with your mentor is just one of the ways to have a successful mentorship.

In addition to concerns about the data supporting the FDA approval of aducanumab for patients with Alzheimer disease, FDA advisory committee members raised some unique concerns when they rejected the application in November 2020.

The shift to telemedicine for patient care for individuals with diabetes showed little negative impact on the metabolic health of these patients.

Many HTCs use these drug pricing arrangements to reduce reliance on limited federal funding.

The FDA has approved the first and only intravenous immunoglobulin indicated for use in adults with dermatomyositis.

Kevin Day, PharmD, president of Day’s Miami Heights Pharmacy in Cincinnati, Ohio, discusses how his independent pharmacy is gearing up for influenza season while continuing to deliver COVID-19 vaccines safely.

This month's featured products include an ophthalmic solution, darifenacin ER tablets, and more.

Study findings could offer a new approach to the toxin-based approach of other C. difficile vaccines in development.

Despite their importance, formal performance appraisal systems are often lacking.

Specific communication among different brain regions, known as brain connectivity, could potentially serve as a biomarker for attention-deficit hyperactivity disorder (ADHD), according to a study published in Frontiers in Physiology.

The drug is an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) for patients with anemia due to chronic kidney disease (CKD).

Zydelig (idelalisib) is a kinase inhibitor approved in 2014 for 3 oncology indications.

HR 841 has bipartisan support, ensuring the FDA recognizes the products as dietary supplements.

Despite the FDA's approval of aducanumab for the treatment of Alzheimer disease with mild cognitive impairments, it has been surrounded by questions.

Trial identifies no new safety signals, as emicizumab continues to demonstrate effective bleeding control with a high proportion of participants achieving zero treated bleeds.

Ten quiz questions to assess your knowledge on common treatments and counseling points for heart failure.